Literature DB >> 9573430

Smoking and cognitive deficits in schizophrenia: a pilot study.

T J Taiminen1, R K Salokangas, S Saarijärvi, H Niemi, H Lehto, V Ahola, E Syvälahti.   

Abstract

The cross-sectional study assessed the associations among smoking status, number of cigarettes smoked per day, and psychiatric symptoms in 88 chronic schizophrenic outpatients with a stable psychic condition. Among the 49 smokers, the number of cigarettes smoked per day was associated with the severity of cognitive symptoms of the Positive and Negative Syndrome Scale. The authors suggest that smoking may alleviate cognitive deficits in schizophrenia by increasing dopaminergic neurotransmission in the prefrontal areas of the brain.

Entities:  

Mesh:

Year:  1998        PMID: 9573430     DOI: 10.1016/s0306-4603(97)00028-2

Source DB:  PubMed          Journal:  Addict Behav        ISSN: 0306-4603            Impact factor:   3.913


  17 in total

Review 1.  Cognitive effects of nicotine: genetic moderators.

Authors:  Aryeh I Herman; Mehmet Sofuoglu
Journal:  Addict Biol       Date:  2010-04-29       Impact factor: 4.280

2.  P50 sensory gating and attentional performance.

Authors:  Li Wan; Bruce H Friedman; Nash N Boutros; Helen J Crawford
Journal:  Int J Psychophysiol       Date:  2007-11-01       Impact factor: 2.997

Review 3.  Nicotinic mechanisms in the treatment of psychotic disorders: a focus on the α7 nicotinic receptor.

Authors:  Ann Olincy; Robert Freedman
Journal:  Handb Exp Pharmacol       Date:  2012

4.  Lower ß2*-nicotinic acetylcholine receptor availability in smokers with schizophrenia.

Authors:  Deepak Cyril D'Souza; Irina Esterlis; Michelle Carbuto; Maegan Krasenics; John Seibyl; Frederic Bois; Brian Pittman; Mohini Ranganathan; Kelly Cosgrove; Julie Staley
Journal:  Am J Psychiatry       Date:  2012-03       Impact factor: 18.112

Review 5.  Treating schizophrenia symptoms with an alpha7 nicotinic agonist, from mice to men.

Authors:  Ann Olincy; Karen E Stevens
Journal:  Biochem Pharmacol       Date:  2007-07-17       Impact factor: 5.858

6.  Smoking in schizophrenia: diagnostic specificity, symptom correlates, and illness severity.

Authors:  Roman Kotov; Lin T Guey; Evelyn J Bromet; Joseph E Schwartz
Journal:  Schizophr Bull       Date:  2008-06-17       Impact factor: 9.306

7.  Cognitive performance and cigarette smoking in first-episode psychosis.

Authors:  Arantzazu Zabala; José Ignacio Eguiluz; Rafael Segarra; Sonsoles Enjuto; Jesús Ezcurra; Ana González Pinto; Miguel Gutiérrez
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2008-06-26       Impact factor: 5.270

8.  In vivo evidence for β2 nicotinic acetylcholine receptor subunit upregulation in smokers as compared with nonsmokers with schizophrenia.

Authors:  Irina Esterlis; Mohini Ranganathan; Frederic Bois; Brian Pittman; Marina R Picciotto; Lara Shearer; Alan Anticevic; Jon Carlson; Mark J Niciu; Kelly P Cosgrove; D Cyril D'Souza
Journal:  Biol Psychiatry       Date:  2013-11-13       Impact factor: 13.382

9.  Socio-demographic and clinical characteristics of heavy and non-heavy smokers among schizophrenia inpatients in a Chinese Han population.

Authors:  Xiang Yang Zhang; Da Chun Chen; Yun Long Tan; Mei Hong Xiu; Jingyi Cui; Li Hui; Fu De Yang; Thomas R Kosten
Journal:  Psychopharmacology (Berl)       Date:  2013-08-21       Impact factor: 4.530

Review 10.  Alpha-7 nicotinic receptor agonists: potential new candidates for the treatment of schizophrenia.

Authors:  Laura F Martin; William R Kem; Robert Freedman
Journal:  Psychopharmacology (Berl)       Date:  2004-02-19       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.